A novel splice variant of the Fas Gene in patients with cutaneous T-cell lymphoma

Cancer Research

Volumn 62, Issue 19, 2002, Pages 5389-5392

  Van Doorn, Remco ^a   Dijkman, Remco ^a   Vermeer, Maarten H ^a   Starink, Theo M ^a   Willemze, Rein ^a   Tensen, Cornelis P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTRON; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; RNA SPLICING; SKIN LYMPHOMA; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIGENS, CD95; BIOPSY; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM STAGING; POINT MUTATION;

EID: 0036791130     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Willemze, R., Kerl H., Sterry, W., Berti, E., Cerroni, L., Chimenti, S., Diaz-Perez, J. L., Geerts, M. L., Goos, M., Knobler, R., Ralfkiaer, E., Santucci, M., Smith, N., Wechsler, J., van Vloten, W. A., and Meijer, C. J. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood, 90: 354-371, 1997.
2. Kikuchi, A., and Nishikawa, T. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Arch. Dermatol., 133: 829-833, 1997.
3. Cascino, I., Papoff, G., De Maria, R., Testi, R., and Ruberti, G. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol., 156: 13-17, 1996.
4. Vaishnaw, A. K., Orlinick, J. R., Chu, J. L., Krammer, P. H., Chao, M. V., and Elkon, K. B. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J. Clin. Investig., 103: 355-363, 1999.
5. Chan, K. F., Siegel, M. R., and Lenardo, J. M. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity, 13: 419-422, 2000.
6. Zoi-Toli, O., Vermeer, M. H., De Vries, E., Van Beek, P., Meijer, C. J., and Willemze, R. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL. Br. J. Dermatol., 143: 313-319, 2000.
7. Gronbaek, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K., Hansen, N. E., Zeuthen, J., Hou-Jensen, K., and Guldberg, P. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood, 92: 3018-3024, 1998.
8. Bunn, P., and Lamberg, S. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat. Rep., 63: 725-728, 1979.
9. Otsuki, T., Sakaguchi, H., Tomokuni, A., Aikoh, T., Matsuki, T., Isozaki, Y., Hyodoh, F., Kawakami, Y., Kusaka, M., Kita, S., and Ueki, A. Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients. Immunol. Lett., 72: 137-143, 2000.
10. Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K., Johnson, M., Lynch, D., Tsien, R. Y., and Lenardo, M. J. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (Wash. DC), 288: 2354-2357, 2000.
11. Jenkins, M., Keir, M., and McCune, J. M. A membrane-bound Fas decoy receptor expressed by human thymocytes. J. Biol. Chem., 275: 7988-7993, 2000.
12. Dereure, O., Levi, E., Vonderheid, E. C., and Kadin, M. E. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J. Investig. Dermatol., 118: 949-956, 2002.
13. Jiang, Z., and Wu, J. Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med., 220: 64-72, 1999.
14. Xerri, L., Hassoun, J., Devilard, E., Birnbaum, D., and Birg, F. BCL-X and the apoptotic machinery of lymphoma cells. Leuk. Lymphoma. 28: 451-458, 1998.
15. Forch, P., Puig, O., Kedersha, N., Martinez, C., Granneman, S., Seraphin, B., Anderson, P., and Valcarcel, J. The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol. Cell, 6: 1089-1098, 2000.
16. Vermeer, M. H., Geelen, F. A., Kummer, J. A., Meijer, C. J., and Willemze, R. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am. J. Pathol., 154: 1203-1210, 1999.